Anavex Life Sciences Corp (AVXL)

[nidan7500]

Special Access Program (SAP) applications are granted at a physicians’ request on behalf of patients. Based on the safety profile of ANAVEX®2-73 (blarcamesine), as well as clinical evidence that the study drug will continue to benefit patients, Anavex will continue its responsibility to support patients post study by facilitating the supply of ANAVEX®2-73 (blarcamesine) to patients in Canada. Approved compassionate programs are also ongoing in the United Kingdom and Australia, representing all regions of the Rett Syndrome study participation.

https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs/guidance.html

Our opponents are surrounded and they do not seem to recognize that fact. Dr.M. has formed a solid force of powerful, capable allies in Canada , UK W/ Australia. AVXL has a WW strategy for regulatory links and Strong clinical performance/results . These are not random acts of a novice management team . We can only observe from a distance. We do not know the details for exact timing (probably a good thing for this board to not know...IMO) . Can you imagine what the FUD crowd would be doing if they had a clock running on , "THE PLAN". UUGGGHHH.